Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) represented a move of 6.01 percent or $-0.37 per share and closed its previous day trading session at $5.47. 868219 Shares were traded in the last trading session with an Average Volume of 1.74 Million Shares. The stock currently has a Market Capitalization of 414.41 Million.
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company’s proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
The stock traded between $1.42 and $6.75 over 1-Year time period showing its price to sales ratio of 13.2. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $15.93 and 200-Day Simple Moving Average of $75.89. Its Price to Free Cash Flow is 0 and Price to Book of 5.02.
Analyst’s recommended the stock as 2.4 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) reported its Actual EPS of $-0.18/share. The analysts offering Earnings Estimates for the company were believing that Arrowhead Pharmaceuticals, Inc. could bring EPS of $-0.16/share. The difference between Actual EPS and Estimated EPS was -0.02 Percent. Thus showing an Earnings Surprise of -12.5 Percent.
SunOpta Inc. (NASDAQ:STKL)
In the last trading session, SunOpta Inc. (NASDAQ:STKL) added its value by 2.16% closing at the price of $7.1. The stock currently has market capitalization of 612.3 Million, with average volume of 303.04 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently SunOpta Inc. (NASDAQ:STKL) is showing beta of 1.34. This particular value of beta suggests that SunOpta Inc. (NASDAQ:STKL) has historically moved 134% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for SunOpta Inc. (NASDAQ:STKL) is at $-0.67.
The stock currently has RSI of 37.53. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
SunOpta Inc. is an operator of high-growth ethical businesses, focusing on integrated business models in the natural and organic food, supplements and health and beauty markets. The Company has three business units: the SunOpta Food Group, which specializes in sourcing, processing and distribution of natural and organic food products integrated from seed through packaged products; the Opta Minerals Group, a producer, distributor, and recycler of environmentally friendly industrial materials; and the SunOpta BioProcess Group which engineers and markets proprietary steam explosion technology systems for the pulp, bio-fuel and food processing industries. Each of these business units has proprietary products and services that give it a solid competitive advantage in its sector.
SunOpta Inc. (NASDAQ:STKL) topped its 52-week high price of $10.20 on 07/03/17 and 52-Week Low Price of $ 6.00 on 03/03/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 3.77% and monthly volatility of 3.25% respectively.